FDG Positron Emission Tomography in Head and Neck Cancer
- 1 December 1999
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Nuclear Medicine
- Vol. 24 (12), 950-4
- https://doi.org/10.1097/00003072-199912000-00009
Abstract
Fluorodeoxyglucose (FDG) positron emission tomography (PET) is a functional imaging technique used for imaging and staging malignant diseases. In many oncologic situations, however, abnormal changes seen on the PET studies are not caused by tumor, which is especially true in the head and neck region. The authors present an overview of the phenomena that may confound the interpretation of the images in head and neck cancer. FDG PET studies were performed in patients with primary head and neck cancer and in patients in whom recurrent disease was likely. The results were correlated with clinical findings. Eight solitary cases were selected from a total of 180 patients studied. Benign lesions and iatrogenic and physiologic changes may show increased FDG uptake. Therefore, clinical information on previous surgical interventions and optimal patient preparation are necessary for adequate interpretation. If these prerequisites can be met, benign lesions appear to be the only lesions that may interfere with the specificity of FDG PET.Keywords
This publication has 10 references indexed in Scilit:
- Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography: preliminary resultsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1998
- The mechanism of accumulation of tumour-localising radiopharmaceuticalsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1998
- Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucoseEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Salivary gland tumors: pretherapy evaluation with PET.Radiology, 1994
- Facilitative glucose transportersEuropean Journal of Biochemistry, 1994
- Quantitative Metabolic PET Imaging of a Plasma Cell GranulomaJournal of Thoracic Imaging, 1994
- Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning.Radiology, 1993
- Over-expression of facilitative glucose transporter genes in human cancerBiochemical and Biophysical Research Communications, 1990
- Elevation of facilitated glucose-transporter messenger RNA in human hepatocellular carcinomaHepatology, 1990